Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells
Authors
Keywords
Major Histocompatibility Complex, Umbilical Cord Blood, Acute GvHD, Chronic GvHD, Donor Lymphocyte Infusion
Journal
BIODRUGS
Volume 27, Issue 6, Pages 605-614
Publisher
Springer Nature
Online
2013-06-27
DOI
10.1007/s40259-013-0050-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy
- (2012) J. B. Canavan et al. BLOOD
- Administration of CD4+CD25highCD127- Regulatory T Cells Preserves -Cell Function in Type 1 Diabetes in Children
- (2012) N. Marek-Trzonkowska et al. DIABETES CARE
- Multiple Unit Pooled Umbilical Cord Blood is a Viable Source of Therapeutic Regulatory T Cells
- (2012) Kate Milward et al. TRANSPLANTATION
- Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
- (2011) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Coating Human Pancreatic Islets With CD4+CD25highCD127− Regulatory T Cells as a Novel Approach for the Local Immunoprotection
- (2011) Natalia Marek et al. ANNALS OF SURGERY
- Can Treg therapy prevent GVHD?
- (2011) K. V. Komanduri et al. BLOOD
- Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
- (2011) H.-J. Shin et al. BLOOD
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- The Time is Crucial for Ex Vivo Expansion of T Regulatory Cells for Therapy
- (2011) Natalia Marek et al. CELL TRANSPLANTATION
- Regulatory T cells in stem cell transplantation: strategies and first clinical experiences
- (2011) Matthias Edinger et al. CURRENT OPINION IN IMMUNOLOGY
- Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex–haplo-identical non-myeloablative hematopoietic cell transplantation
- (2011) Yun Chen et al. CYTOTHERAPY
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells
- (2010) Piotr Trzonkowski et al. MECHANISMS OF AGEING AND DEVELOPMENT
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Regulatory T cells for the prevention of graft-versus-host disease: Professionals defeat amateurs
- (2009) Matthias Edinger EUROPEAN JOURNAL OF IMMUNOLOGY
- Alloantigen-specificde novo-induced Foxp3+Treg revertin vivoand do not protect from experimental GVHD
- (2009) Christian Koenecke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells
- (2009) Alexandr V. Bazhin et al. MOLECULAR IMMUNOLOGY
- From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly
- (2008) Piotr Trzonkowski et al. BIOGERONTOLOGY
- Ex vivo expansion of CD4+CD25+T regulatory cells for immunosuppressive therapy
- (2008) Piotr Trzonkowski et al. CYTOMETRY PART A
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started